| 0 |
APPLICATION SITE LYMPHADENOPATHY |
1 |
1.0000 |
| 1 |
CARCINOMA IN SITU OF PENIS |
1 |
0.0909 |
| 2 |
ORF |
2 |
0.0556 |
| 3 |
CHRONIC PAPILLOMATOUS DERMATITIS |
4 |
0.0548 |
| 4 |
CUTANEOUS T-CELL LYMPHOMA REFRACTORY |
1 |
0.0476 |
| 5 |
APPLICATION SITE PLAQUE |
1 |
0.0435 |
| 6 |
ALCALIGENES INFECTION |
1 |
0.0417 |
| 7 |
ADMINISTRATION SITE ULCER |
1 |
0.0417 |
| 8 |
ACHROMOTRICHIA ACQUIRED |
2 |
0.0408 |
| 9 |
EPIDERMODYSPLASIA VERRUCIFORMIS |
6 |
0.0357 |
| 10 |
ACTINIC CHEILITIS |
1 |
0.0345 |
| 11 |
BASOSQUAMOUS CARCINOMA OF SKIN |
2 |
0.0345 |
| 12 |
VULVAR DYSPLASIA |
4 |
0.0336 |
| 13 |
APPLICATION SITE ULCER |
23 |
0.0325 |
| 14 |
APPLICATION SITE ATROPHY |
1 |
0.0303 |
| 15 |
BAND NEUTROPHIL PERCENTAGE DECREASED |
1 |
0.0303 |
| 16 |
DERMOID CYST |
9 |
0.0270 |
| 17 |
MOLLUSCUM CONTAGIOSUM |
14 |
0.0259 |
| 18 |
INTERVERTEBRAL DISC CALCIFICATION |
2 |
0.0220 |
| 19 |
APPLICATION SITE SCAB |
47 |
0.0217 |
| 20 |
CSF PROTEIN ABNORMAL |
1 |
0.0217 |
| 21 |
CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS |
9 |
0.0201 |
| 22 |
APPLICATION SITE NECROSIS |
2 |
0.0194 |
| 23 |
CYTOKINE ABNORMAL |
1 |
0.0192 |
| 24 |
ACANTHOMA |
1 |
0.0192 |
| 25 |
APPLICATION SITE INFLAMMATION |
24 |
0.0173 |
| 26 |
ANOGENITAL WARTS |
15 |
0.0168 |
| 27 |
BACTEROIDES TEST POSITIVE |
1 |
0.0152 |
| 28 |
ACANTHOLYSIS |
1 |
0.0152 |
| 29 |
APPLICATION SITE DISCHARGE |
17 |
0.0147 |
| 30 |
CARDIAC PACEMAKER REMOVAL |
1 |
0.0147 |
| 31 |
AUTOIMMUNE RETINOPATHY |
1 |
0.0137 |
| 32 |
ALCOHOLIC SEIZURE |
1 |
0.0135 |
| 33 |
BASOSQUAMOUS CARCINOMA |
2 |
0.0134 |
| 34 |
BONE METABOLISM DISORDER |
4 |
0.0133 |
| 35 |
SKIN DEPIGMENTATION |
17 |
0.0125 |
| 36 |
APPLICATION SITE EROSION |
16 |
0.0124 |
| 37 |
GRANULOMATOUS DERMATITIS |
3 |
0.0123 |
| 38 |
ADMINISTRATION SITE WARMTH |
1 |
0.0122 |
| 39 |
APPLICATION SITE BLEEDING |
3 |
0.0121 |
| 40 |
LOCAL REACTION |
9 |
0.0121 |
| 41 |
ADMINISTRATION SITE INFLAMMATION |
1 |
0.0111 |
| 42 |
POROKERATOSIS |
2 |
0.0109 |
| 43 |
APPLICATION SITE SCAR |
13 |
0.0104 |
| 44 |
MACULAR SCAR |
2 |
0.0103 |
| 45 |
APPLICATION SITE HYPERAESTHESIA |
1 |
0.0101 |
| 46 |
PERIORBITAL DISORDER |
2 |
0.0098 |
| 47 |
ADENOCARCINOMA METASTATIC |
2 |
0.0097 |
| 48 |
ALOPECIA TOTALIS |
3 |
0.0091 |
| 49 |
NEUROPSYCHIATRIC SYNDROME |
2 |
0.0091 |
| 50 |
ECTROPION |
3 |
0.0089 |
| 51 |
KERATOACANTHOMA |
6 |
0.0088 |
| 52 |
PITYRIASIS RUBRA PILARIS |
2 |
0.0084 |
| 53 |
PNEUMOTHORAX TRAUMATIC |
2 |
0.0083 |
| 54 |
CHEMICAL BURN OF GENITALIA |
1 |
0.0082 |
| 55 |
GENITAL ERYTHEMA |
4 |
0.0081 |
| 56 |
SKIN EROSION |
26 |
0.0081 |
| 57 |
PENILE ERYTHEMA |
3 |
0.0080 |
| 58 |
ACTINIC KERATOSIS |
20 |
0.0077 |
| 59 |
CERVIX CARCINOMA STAGE III |
1 |
0.0076 |
| 60 |
BOWEN'S DISEASE |
1 |
0.0074 |
| 61 |
LICHENIFICATION |
3 |
0.0073 |
| 62 |
BULBAR PALSY |
2 |
0.0072 |
| 63 |
APPLICATION SITE DISCOLOURATION |
29 |
0.0071 |
| 64 |
SCAB |
77 |
0.0067 |
| 65 |
ANOGENITAL DYSPLASIA |
1 |
0.0067 |
| 66 |
APPLICATION SITE HAEMORRHAGE |
18 |
0.0066 |
| 67 |
ANAL SQUAMOUS CELL CARCINOMA |
2 |
0.0065 |
| 68 |
WOUND INFECTION PSEUDOMONAS |
2 |
0.0064 |
| 69 |
CHROMOSOMAL DELETION |
1 |
0.0063 |
| 70 |
ACTIVITIES OF DAILY LIVING DECREASED |
4 |
0.0063 |
| 71 |
APPLICATION SITE OEDEMA |
2 |
0.0062 |
| 72 |
APPLICATION SITE WOUND |
1 |
0.0061 |
| 73 |
PAPILLOMA VIRAL INFECTION |
10 |
0.0061 |
| 74 |
APPLICATION SITE INFECTION |
3 |
0.0059 |
| 75 |
APPLICATION SITE INDURATION |
1 |
0.0059 |
| 76 |
LIP EROSION |
4 |
0.0055 |
| 77 |
APPLICATION SITE PUSTULES |
2 |
0.0055 |
| 78 |
B-LYMPHOCYTE COUNT INCREASED |
1 |
0.0054 |
| 79 |
APPLICATION SITE INJURY |
1 |
0.0053 |
| 80 |
APPLICATION SITE SWELLING |
25 |
0.0050 |
| 81 |
LIP BLISTER |
13 |
0.0048 |
| 82 |
CUTANEOUS SARCOIDOSIS |
2 |
0.0046 |
| 83 |
COLORECTAL ADENOCARCINOMA |
1 |
0.0045 |
| 84 |
CHRONIC GRAFT VERSUS HOST DISEASE ORAL |
1 |
0.0041 |
| 85 |
BRAIN STEM SYNDROME |
3 |
0.0040 |
| 86 |
SKIN PAPILLOMA |
16 |
0.0040 |
| 87 |
CHRONIC DISEASE |
1 |
0.0039 |
| 88 |
APPLICATION SITE ERYTHEMA |
102 |
0.0039 |
| 89 |
KELOID SCAR |
2 |
0.0039 |
| 90 |
CONJUNCTIVITIS VIRAL |
1 |
0.0038 |
| 91 |
APPLICATION SITE PAPULES |
4 |
0.0038 |
| 92 |
LIP ERYTHEMA |
3 |
0.0038 |
| 93 |
CORNEAL EROSION |
2 |
0.0037 |
| 94 |
ERYTHRODERMIC PSORIASIS |
3 |
0.0036 |
| 95 |
CHEMICAL BURNS OF EYE |
1 |
0.0036 |
| 96 |
INTRACRANIAL HAEMATOMA |
2 |
0.0036 |
| 97 |
LIP PAIN |
10 |
0.0035 |
| 98 |
METASTATIC MALIGNANT MELANOMA |
8 |
0.0035 |
| 99 |
EYE ULCER |
2 |
0.0035 |
| 100 |
CHEMICAL BURN |
4 |
0.0035 |
| 101 |
APPLICATION SITE PAIN |
75 |
0.0034 |
| 102 |
APPLICATION SITE VESICLES |
22 |
0.0034 |
| 103 |
SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS |
6 |
0.0034 |
| 104 |
MEAN PLATELET VOLUME INCREASED |
2 |
0.0033 |
| 105 |
APPLICATION SITE HYPERSENSITIVITY |
4 |
0.0033 |
| 106 |
HUMAN HERPESVIRUS 8 INFECTION |
2 |
0.0033 |
| 107 |
PUNCTATE KERATITIS |
3 |
0.0033 |
| 108 |
ORAL MUCOSA EROSION |
4 |
0.0033 |
| 109 |
APPLICATION SITE DRYNESS |
11 |
0.0032 |
| 110 |
XEROSIS |
4 |
0.0032 |
| 111 |
ARTERITIS |
2 |
0.0032 |
| 112 |
LIP HAEMORRHAGE |
4 |
0.0031 |
| 113 |
APPLICATION SITE REACTION |
22 |
0.0031 |
| 114 |
ANAL CANCER |
3 |
0.0031 |
| 115 |
CUTANEOUS LUPUS ERYTHEMATOSUS |
6 |
0.0031 |
| 116 |
ADMINISTRATION SITE SWELLING |
1 |
0.0031 |
| 117 |
ACANTHOSIS |
1 |
0.0030 |
| 118 |
HYPERAEMIA |
6 |
0.0030 |
| 119 |
QUADRIPARESIS |
5 |
0.0030 |
| 120 |
CAROTID ARTERY ANEURYSM |
1 |
0.0029 |
| 121 |
APPLICATION SITE EXFOLIATION |
12 |
0.0029 |
| 122 |
WOUND SECRETION |
11 |
0.0028 |
| 123 |
APPLICATION SITE DISCOMFORT |
5 |
0.0028 |
| 124 |
SKIN REACTION |
39 |
0.0028 |
| 125 |
ANKLE ARTHROPLASTY |
1 |
0.0028 |
| 126 |
ESCHAR |
2 |
0.0027 |
| 127 |
PRECANCEROUS SKIN LESION |
4 |
0.0027 |
| 128 |
PATHOGEN RESISTANCE |
24 |
0.0026 |
| 129 |
GENITAL ULCERATION |
2 |
0.0026 |
| 130 |
LIP ULCERATION |
3 |
0.0026 |
| 131 |
PURULENCE |
5 |
0.0026 |
| 132 |
VITILIGO |
6 |
0.0026 |
| 133 |
SQUAMOUS CELL CARCINOMA OF SKIN |
15 |
0.0025 |
| 134 |
BLOOD IMMUNOGLOBULIN G INCREASED |
3 |
0.0025 |
| 135 |
BALANOPOSTHITIS |
2 |
0.0024 |
| 136 |
MYCOSIS FUNGOIDES |
2 |
0.0024 |
| 137 |
MALIGNANT MELANOMA IN SITU |
3 |
0.0024 |
| 138 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
12 |
0.0024 |
| 139 |
SKIN PLAQUE |
20 |
0.0024 |
| 140 |
APPLICATION SITE WARMTH |
3 |
0.0024 |
| 141 |
CORONA VIRUS INFECTION |
1 |
0.0023 |
| 142 |
RENAL TUBULAR ACIDOSIS |
5 |
0.0023 |
| 143 |
SKIN HYPOPIGMENTATION |
4 |
0.0023 |
| 144 |
LIP EXFOLIATION |
3 |
0.0023 |
| 145 |
BASAL CELL CARCINOMA |
34 |
0.0022 |
| 146 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
2 |
0.0022 |
| 147 |
LICHEN PLANUS |
5 |
0.0022 |
| 148 |
ERYTHEMA MULTIFORME |
20 |
0.0021 |
| 149 |
APPLICATION SITE IRRITATION |
26 |
0.0021 |
| 150 |
TELANGIECTASIA |
2 |
0.0021 |
| 151 |
DUODENAL PERFORATION |
2 |
0.0020 |
| 152 |
GENITAL PAIN |
3 |
0.0020 |
| 153 |
DERMATITIS INFECTED |
1 |
0.0020 |
| 154 |
IMPETIGO |
3 |
0.0020 |
| 155 |
HYPERPARATHYROIDISM SECONDARY |
5 |
0.0020 |
| 156 |
THERAPY PARTIAL RESPONDER |
31 |
0.0020 |
| 157 |
ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC |
3 |
0.0020 |
| 158 |
AORTIC VALVE CALCIFICATION |
1 |
0.0019 |
| 159 |
CONJUNCTIVAL OEDEMA |
2 |
0.0019 |
| 160 |
SKIN ULCER |
49 |
0.0019 |
| 161 |
ASPARTATE AMINOTRANSFERASE DECREASED |
1 |
0.0019 |
| 162 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
5 |
0.0019 |
| 163 |
CHEILITIS |
10 |
0.0018 |
| 164 |
HYPERKERATOSIS |
10 |
0.0018 |
| 165 |
BLOOD PH INCREASED |
1 |
0.0018 |
| 166 |
SQUAMOUS CELL CARCINOMA |
17 |
0.0018 |
| 167 |
LINEAR IGA DISEASE |
3 |
0.0018 |
| 168 |
AORTIC DILATATION |
2 |
0.0018 |
| 169 |
GASTROINTESTINAL ULCER HAEMORRHAGE |
2 |
0.0018 |
| 170 |
BLOODY DISCHARGE |
2 |
0.0017 |
| 171 |
INTERNATIONAL NORMALISED RATIO ABNORMAL |
6 |
0.0017 |
| 172 |
SKIN WEEPING |
6 |
0.0017 |
| 173 |
BLOOD VISCOSITY INCREASED |
1 |
0.0017 |
| 174 |
BLOOD IMMUNOGLOBULIN M INCREASED |
1 |
0.0016 |
| 175 |
VULVOVAGINAL SWELLING |
3 |
0.0016 |
| 176 |
STAPHYLOCOCCAL SKIN INFECTION |
2 |
0.0016 |
| 177 |
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS |
4 |
0.0016 |
| 178 |
MULTIPLE-DRUG RESISTANCE |
5 |
0.0016 |
| 179 |
ARTHRITIS REACTIVE |
1 |
0.0016 |
| 180 |
INFECTED SKIN ULCER |
3 |
0.0016 |
| 181 |
LIP DISCOLOURATION |
2 |
0.0016 |
| 182 |
SKIN NECROSIS |
8 |
0.0015 |
| 183 |
HERPES SIMPLEX |
10 |
0.0015 |
| 184 |
APPLICATION SITE PARAESTHESIA |
2 |
0.0015 |
| 185 |
HYPOGEUSIA |
3 |
0.0015 |
| 186 |
DEAFNESS NEUROSENSORY |
5 |
0.0015 |
| 187 |
NEPHROGENIC ANAEMIA |
7 |
0.0015 |
| 188 |
CUTANEOUS SYMPTOM |
1 |
0.0015 |
| 189 |
INTESTINAL MASS |
2 |
0.0015 |
| 190 |
APPLICATION SITE PRURITUS |
33 |
0.0015 |
| 191 |
PEMPHIGUS |
18 |
0.0014 |
| 192 |
ALCOHOL INTOLERANCE |
1 |
0.0014 |
| 193 |
APALLIC SYNDROME |
1 |
0.0014 |
| 194 |
BENIGN NEOPLASM OF THYROID GLAND |
1 |
0.0014 |
| 195 |
LEUKOENCEPHALOPATHY |
5 |
0.0013 |
| 196 |
LICHENOID KERATOSIS |
3 |
0.0013 |
| 197 |
APHTHOUS STOMATITIS |
3 |
0.0013 |
| 198 |
NEUROLOGICAL DECOMPENSATION |
3 |
0.0013 |
| 199 |
NEOPLASM SKIN |
2 |
0.0013 |
| 200 |
BLOOD ALCOHOL INCREASED |
1 |
0.0013 |
| 201 |
TRANSCRIPTION MEDICATION ERROR |
2 |
0.0013 |
| 202 |
BLISTER INFECTED |
1 |
0.0013 |
| 203 |
INFLUENZA LIKE ILLNESS |
103 |
0.0013 |
| 204 |
CHEMICAL INJURY |
1 |
0.0012 |
| 205 |
ANAL ULCER |
1 |
0.0012 |
| 206 |
LUPUS-LIKE SYNDROME |
11 |
0.0012 |
| 207 |
PENIS DISORDER |
3 |
0.0012 |
| 208 |
CIRCADIAN RHYTHM SLEEP DISORDER |
1 |
0.0012 |
| 209 |
DRUG RESISTANCE |
31 |
0.0012 |
| 210 |
WOUND INFECTION STAPHYLOCOCCAL |
2 |
0.0012 |
| 211 |
OTORRHOEA |
2 |
0.0011 |
| 212 |
BURNS SECOND DEGREE |
2 |
0.0011 |
| 213 |
FANCONI SYNDROME ACQUIRED |
2 |
0.0011 |
| 214 |
CEREBELLAR ATROPHY |
1 |
0.0011 |
| 215 |
PIGMENTATION DISORDER |
7 |
0.0011 |
| 216 |
SKIN LESION |
31 |
0.0011 |
| 217 |
CONJUNCTIVAL HYPERAEMIA |
4 |
0.0011 |
| 218 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
8 |
0.0011 |
| 219 |
ARTERIOVENOUS MALFORMATION |
1 |
0.0011 |
| 220 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
1 |
0.0011 |
| 221 |
ADENOCARCINOMA GASTRIC |
1 |
0.0011 |
| 222 |
PLASMACYTOMA |
2 |
0.0011 |
| 223 |
APPLICATION SITE DERMATITIS |
1 |
0.0011 |
| 224 |
SKIN HYPERTROPHY |
3 |
0.0011 |
| 225 |
BUNDLE BRANCH BLOCK |
1 |
0.0011 |
| 226 |
BRAIN STEM HAEMORRHAGE |
1 |
0.0011 |
| 227 |
ECONOMIC PROBLEM |
16 |
0.0011 |
| 228 |
CANCER SURGERY |
1 |
0.0010 |
| 229 |
APHTHOUS ULCER |
8 |
0.0010 |
| 230 |
SKIN IRRITATION |
47 |
0.0010 |
| 231 |
COLON ADENOMA |
1 |
0.0010 |
| 232 |
APPLICATION SITE BURN |
5 |
0.0010 |
| 233 |
CELL DEATH |
2 |
0.0010 |
| 234 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
55 |
0.0010 |
| 235 |
BLOOD IMMUNOGLOBULIN M DECREASED |
1 |
0.0010 |
| 236 |
PAPULE |
7 |
0.0010 |
| 237 |
CAROTID ARTERIOSCLEROSIS |
1 |
0.0010 |
| 238 |
ALVEOLITIS ALLERGIC |
1 |
0.0010 |
| 239 |
CAPILLARY LEAK SYNDROME |
2 |
0.0010 |
| 240 |
SKIN INDURATION |
2 |
0.0010 |
| 241 |
LUNG ABSCESS |
2 |
0.0010 |
| 242 |
CATATONIA |
5 |
0.0010 |
| 243 |
ANHEDONIA |
25 |
0.0010 |
| 244 |
BURNS THIRD DEGREE |
1 |
0.0009 |
| 245 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
1 |
0.0009 |
| 246 |
AMAUROSIS FUGAX |
1 |
0.0009 |
| 247 |
GRAFT VERSUS HOST DISEASE IN SKIN |
2 |
0.0009 |
| 248 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
5 |
0.0009 |
| 249 |
ERYTHEMA |
185 |
0.0009 |
| 250 |
TONGUE BLISTERING |
2 |
0.0009 |
| 251 |
DISTRIBUTIVE SHOCK |
2 |
0.0009 |
| 252 |
HAEMATOCRIT INCREASED |
2 |
0.0009 |
| 253 |
ACUTE PRERENAL FAILURE |
1 |
0.0009 |
| 254 |
PRURITUS GENITAL |
2 |
0.0008 |
| 255 |
WRONG DOSE |
2 |
0.0008 |
| 256 |
PANNICULITIS |
2 |
0.0008 |
| 257 |
ULCER |
13 |
0.0008 |
| 258 |
VIRAL MUTATION IDENTIFIED |
3 |
0.0008 |
| 259 |
STEVENS-JOHNSON SYNDROME |
18 |
0.0008 |
| 260 |
BLOOD UREA DECREASED |
1 |
0.0008 |
| 261 |
ALLERGY TO CHEMICALS |
1 |
0.0008 |
| 262 |
CUTANEOUS T-CELL LYMPHOMA |
1 |
0.0008 |
| 263 |
CARDIOTOXICITY |
7 |
0.0008 |
| 264 |
OEDEMA |
42 |
0.0008 |
| 265 |
ANION GAP INCREASED |
1 |
0.0007 |
| 266 |
B-LYMPHOCYTE COUNT DECREASED |
1 |
0.0007 |
| 267 |
GASTRIC PERFORATION |
2 |
0.0007 |
| 268 |
CALCULUS BLADDER |
1 |
0.0007 |
| 269 |
CORNEAL OPACITY |
1 |
0.0007 |
| 270 |
SELF-MEDICATION |
3 |
0.0007 |
| 271 |
HYPERURICAEMIA |
3 |
0.0007 |
| 272 |
OSTEOPENIA |
11 |
0.0007 |
| 273 |
LIP SWELLING |
24 |
0.0007 |
| 274 |
CHOLECYSTITIS INFECTIVE |
2 |
0.0007 |
| 275 |
PRODUCT USE IN UNAPPROVED INDICATION |
177 |
0.0007 |
| 276 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
13 |
0.0007 |
| 277 |
IMMUNE THROMBOCYTOPENIC PURPURA |
2 |
0.0007 |
| 278 |
TONGUE DISCOMFORT |
3 |
0.0007 |
| 279 |
PURULENT DISCHARGE |
3 |
0.0007 |
| 280 |
CEREBELLAR HAEMORRHAGE |
1 |
0.0007 |
| 281 |
INFLAMMATION |
36 |
0.0007 |
| 282 |
PHARYNGEAL DISORDER |
2 |
0.0007 |
| 283 |
CHAPPED LIPS |
3 |
0.0007 |
| 284 |
MOTOR DYSFUNCTION |
7 |
0.0007 |
| 285 |
RASH PUSTULAR |
5 |
0.0007 |
| 286 |
VULVOVAGINAL DISCOMFORT |
3 |
0.0007 |
| 287 |
FACIAL PAIN |
6 |
0.0007 |
| 288 |
ORAL PAIN |
15 |
0.0007 |
| 289 |
ATYPICAL PNEUMONIA |
2 |
0.0007 |
| 290 |
SCRATCH |
7 |
0.0007 |
| 291 |
KERATITIS |
2 |
0.0007 |
| 292 |
PROSTATITIS |
2 |
0.0007 |
| 293 |
LYMPHADENOPATHY |
23 |
0.0006 |
| 294 |
ORAL DISCOMFORT |
9 |
0.0006 |
| 295 |
PRODUCT PRESCRIBING ISSUE |
14 |
0.0006 |
| 296 |
BLISTER |
36 |
0.0006 |
| 297 |
BACTERIAL VAGINOSIS |
1 |
0.0006 |
| 298 |
SECRETION DISCHARGE |
8 |
0.0006 |
| 299 |
SKIN TIGHTNESS |
3 |
0.0006 |
| 300 |
SKIN ABRASION |
3 |
0.0006 |
| 301 |
PHOTOPSIA |
4 |
0.0006 |
| 302 |
POLYMYALGIA RHEUMATICA |
2 |
0.0006 |
| 303 |
VULVOVAGINAL PAIN |
3 |
0.0006 |
| 304 |
COLON CANCER METASTATIC |
1 |
0.0006 |
| 305 |
ACUTE LEUKAEMIA |
1 |
0.0006 |
| 306 |
COSTOCHONDRITIS |
1 |
0.0006 |
| 307 |
DERMATITIS CONTACT |
7 |
0.0006 |
| 308 |
LYMPHOCYTE COUNT INCREASED |
2 |
0.0006 |
| 309 |
SKIN INJURY |
2 |
0.0006 |
| 310 |
END STAGE RENAL DISEASE |
11 |
0.0006 |
| 311 |
EYELID OEDEMA |
7 |
0.0006 |
| 312 |
HEPATIC ENZYME ABNORMAL |
3 |
0.0006 |
| 313 |
BK VIRUS INFECTION |
2 |
0.0006 |
| 314 |
CLOSTRIDIAL INFECTION |
2 |
0.0006 |
| 315 |
B-CELL LYMPHOMA |
2 |
0.0006 |
| 316 |
SCAR |
10 |
0.0006 |
| 317 |
BLOOD CHLORIDE INCREASED |
1 |
0.0006 |
| 318 |
TENDERNESS |
6 |
0.0006 |
| 319 |
ALOPECIA AREATA |
1 |
0.0006 |
| 320 |
SKIN DISORDER |
19 |
0.0006 |
| 321 |
DERMATITIS BULLOUS |
4 |
0.0006 |
| 322 |
BLOOD HIV RNA INCREASED |
1 |
0.0006 |
| 323 |
SPONDYLITIS |
2 |
0.0005 |
| 324 |
CHILLS |
64 |
0.0005 |
| 325 |
CONDUCTION DISORDER |
1 |
0.0005 |
| 326 |
BODY TEMPERATURE ABNORMAL |
1 |
0.0005 |
| 327 |
WOUND HAEMORRHAGE |
2 |
0.0005 |
| 328 |
NECROSIS |
3 |
0.0005 |
| 329 |
PROTEIN TOTAL DECREASED |
2 |
0.0005 |
| 330 |
PAROSMIA |
4 |
0.0005 |
| 331 |
BLOOD BICARBONATE DECREASED |
1 |
0.0005 |
| 332 |
MOUTH ULCERATION |
11 |
0.0005 |
| 333 |
HERPES VIRUS INFECTION |
3 |
0.0005 |
| 334 |
PRODUCT LABEL CONFUSION |
3 |
0.0005 |
| 335 |
ATROPHY |
1 |
0.0005 |
| 336 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
1 |
0.0005 |
| 337 |
ORAL HERPES |
10 |
0.0005 |
| 338 |
RENAL TUBULAR NECROSIS |
5 |
0.0005 |
| 339 |
TRIGEMINAL NEURALGIA |
2 |
0.0005 |
| 340 |
RASH PAPULAR |
11 |
0.0005 |
| 341 |
DERMATITIS PSORIASIFORM |
1 |
0.0005 |
| 342 |
THERAPY NON-RESPONDER |
22 |
0.0005 |
| 343 |
ANAL PRURITUS |
1 |
0.0005 |
| 344 |
RED CELL DISTRIBUTION WIDTH INCREASED |
2 |
0.0005 |
| 345 |
SKIN EXFOLIATION |
40 |
0.0005 |
| 346 |
SKIN HAEMORRHAGE |
7 |
0.0005 |
| 347 |
EYE IRRITATION |
27 |
0.0005 |
| 348 |
HEPATIC PAIN |
2 |
0.0005 |
| 349 |
PSEUDOMONAS INFECTION |
4 |
0.0005 |
| 350 |
BLOOD TESTOSTERONE INCREASED |
1 |
0.0005 |
| 351 |
SKIN SWELLING |
4 |
0.0005 |
| 352 |
CHRONIC KIDNEY DISEASE |
35 |
0.0005 |
| 353 |
CERVICAL DYSPLASIA |
1 |
0.0005 |
| 354 |
GINGIVAL SWELLING |
2 |
0.0005 |
| 355 |
ADVERSE REACTION |
6 |
0.0005 |
| 356 |
EJECTION FRACTION DECREASED |
7 |
0.0004 |
| 357 |
WHEELCHAIR USER |
2 |
0.0004 |
| 358 |
NERVE INJURY |
5 |
0.0004 |
| 359 |
BONE DENSITY DECREASED |
14 |
0.0004 |
| 360 |
SKIN INFECTION |
5 |
0.0004 |
| 361 |
APPLICATION SITE URTICARIA |
1 |
0.0004 |
| 362 |
BLOOD LOSS ANAEMIA |
1 |
0.0004 |
| 363 |
LIP DRY |
4 |
0.0004 |
| 364 |
URINE ABNORMALITY |
2 |
0.0004 |
| 365 |
HAEMOGLOBIN INCREASED |
2 |
0.0004 |
| 366 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
2 |
0.0004 |
| 367 |
CYTOMEGALOVIRUS COLITIS |
1 |
0.0004 |
| 368 |
MULTIPLE FRACTURES |
7 |
0.0004 |
| 369 |
DUODENAL ULCER |
3 |
0.0004 |
| 370 |
STAPHYLOCOCCAL INFECTION |
14 |
0.0004 |
| 371 |
HAND FRACTURE |
3 |
0.0004 |
| 372 |
THERMAL BURN |
3 |
0.0004 |
| 373 |
RETCHING |
9 |
0.0004 |
| 374 |
BLOOD IRON DECREASED |
5 |
0.0004 |
| 375 |
BLOOD IMMUNOGLOBULIN E INCREASED |
1 |
0.0004 |
| 376 |
TREATMENT FAILURE |
34 |
0.0004 |
| 377 |
CARTILAGE INJURY |
1 |
0.0004 |
| 378 |
STAPHYLOCOCCAL SEPSIS |
2 |
0.0004 |
| 379 |
HYPERVOLAEMIA |
2 |
0.0004 |
| 380 |
BLOOD IMMUNOGLOBULIN G DECREASED |
1 |
0.0004 |
| 381 |
BLOOD COUNT ABNORMAL |
6 |
0.0004 |
| 382 |
CHEMICAL BURN OF SKIN |
1 |
0.0004 |
| 383 |
APPENDICITIS PERFORATED |
1 |
0.0004 |
| 384 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
4 |
0.0004 |
| 385 |
INCREASED UPPER AIRWAY SECRETION |
2 |
0.0004 |
| 386 |
GAIT INABILITY |
13 |
0.0004 |
| 387 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
4 |
0.0004 |
| 388 |
RENAL CYST |
3 |
0.0004 |
| 389 |
TRANSPLANT REJECTION |
3 |
0.0004 |
| 390 |
BLOOD DISORDER |
3 |
0.0004 |
| 391 |
MALIGNANT MELANOMA |
5 |
0.0004 |
| 392 |
SENSORY LOSS |
3 |
0.0004 |
| 393 |
VIROLOGIC FAILURE |
2 |
0.0004 |
| 394 |
PAIN OF SKIN |
10 |
0.0004 |
| 395 |
BURNING SENSATION |
26 |
0.0004 |
| 396 |
APPLICATION SITE RASH |
5 |
0.0004 |
| 397 |
DEAFNESS UNILATERAL |
2 |
0.0004 |
| 398 |
SECOND PRIMARY MALIGNANCY |
3 |
0.0004 |
| 399 |
STREPTOCOCCAL INFECTION |
2 |
0.0004 |
| 400 |
SKIN FISSURES |
7 |
0.0004 |
| 401 |
NEPHROPATHY TOXIC |
4 |
0.0004 |
| 402 |
BLOOD PRESSURE ABNORMAL |
7 |
0.0004 |
| 403 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
25 |
0.0004 |
| 404 |
SKIN HYPERPIGMENTATION |
3 |
0.0003 |
| 405 |
ANURIA |
3 |
0.0003 |
| 406 |
IMPAIRED QUALITY OF LIFE |
5 |
0.0003 |
| 407 |
SKIN ATROPHY |
2 |
0.0003 |
| 408 |
MOUTH SWELLING |
2 |
0.0003 |
| 409 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
10 |
0.0003 |
| 410 |
RIB FRACTURE |
7 |
0.0003 |
| 411 |
ENERGY INCREASED |
2 |
0.0003 |
| 412 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
12 |
0.0003 |
| 413 |
OSTEONECROSIS |
11 |
0.0003 |
| 414 |
RASH ERYTHEMATOUS |
16 |
0.0003 |
| 415 |
DERMATITIS |
7 |
0.0003 |
| 416 |
BONE LOSS |
5 |
0.0003 |
| 417 |
BLOOD PRESSURE INADEQUATELY CONTROLLED |
2 |
0.0003 |
| 418 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
1 |
0.0003 |
| 419 |
TOXIC EPIDERMAL NECROLYSIS |
5 |
0.0003 |
| 420 |
RETINAL DETACHMENT |
3 |
0.0003 |
| 421 |
IRON DEFICIENCY ANAEMIA |
3 |
0.0003 |
| 422 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
2 |
0.0003 |
| 423 |
EYE SWELLING |
12 |
0.0003 |
| 424 |
DEMENTIA |
9 |
0.0003 |
| 425 |
FLANK PAIN |
3 |
0.0003 |
| 426 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 427 |
LACERATION |
3 |
0.0003 |
| 428 |
SWELLING OF EYELID |
2 |
0.0003 |
| 429 |
SPINAL DISORDER |
3 |
0.0003 |
| 430 |
OSTEOPOROSIS |
13 |
0.0003 |
| 431 |
INTERNATIONAL NORMALISED RATIO INCREASED |
9 |
0.0003 |
| 432 |
BLADDER PAIN |
1 |
0.0003 |
| 433 |
ANGINA PECTORIS |
9 |
0.0003 |
| 434 |
TREATMENT NONCOMPLIANCE |
17 |
0.0003 |
| 435 |
DYSGEUSIA |
23 |
0.0003 |
| 436 |
EAR PAIN |
6 |
0.0003 |
| 437 |
REFUSAL OF TREATMENT BY PATIENT |
2 |
0.0003 |
| 438 |
BEDRIDDEN |
4 |
0.0003 |
| 439 |
OFF LABEL USE |
265 |
0.0003 |
| 440 |
HYPONATRAEMIA |
17 |
0.0003 |
| 441 |
APPETITE DISORDER |
2 |
0.0003 |
| 442 |
SKIN MASS |
2 |
0.0003 |
| 443 |
ANXIETY DISORDER |
1 |
0.0003 |
| 444 |
EYE PRURITUS |
10 |
0.0003 |
| 445 |
HERPES ZOSTER |
17 |
0.0003 |
| 446 |
TASTE DISORDER |
6 |
0.0003 |
| 447 |
ULCER HAEMORRHAGE |
2 |
0.0003 |
| 448 |
DISEASE RECURRENCE |
14 |
0.0003 |
| 449 |
MYALGIA |
50 |
0.0003 |
| 450 |
EUPHORIC MOOD |
3 |
0.0003 |
| 451 |
SKELETAL INJURY |
3 |
0.0003 |
| 452 |
EYE DISCHARGE |
3 |
0.0003 |
| 453 |
DERMATITIS EXFOLIATIVE GENERALISED |
1 |
0.0003 |
| 454 |
AUTOIMMUNE HEPATITIS |
2 |
0.0003 |
| 455 |
AORTIC STENOSIS |
1 |
0.0003 |
| 456 |
CAROTID ARTERY STENOSIS |
1 |
0.0003 |
| 457 |
CLOSTRIDIUM DIFFICILE COLITIS |
3 |
0.0003 |
| 458 |
SKIN DISCOLOURATION |
13 |
0.0003 |
| 459 |
NIGHT SWEATS |
9 |
0.0003 |
| 460 |
SKIN CANCER |
6 |
0.0003 |
| 461 |
DECREASED ACTIVITY |
3 |
0.0003 |
| 462 |
VISUAL FIELD DEFECT |
2 |
0.0003 |
| 463 |
BACK INJURY |
3 |
0.0003 |
| 464 |
APATHY |
4 |
0.0003 |
| 465 |
INTENTIONAL UNDERDOSE |
2 |
0.0003 |
| 466 |
MAJOR DEPRESSION |
2 |
0.0003 |
| 467 |
ORAL DISORDER |
2 |
0.0003 |
| 468 |
MOUTH HAEMORRHAGE |
2 |
0.0003 |
| 469 |
TRANSAMINASES INCREASED |
6 |
0.0003 |
| 470 |
SUNBURN |
2 |
0.0003 |
| 471 |
PEMPHIGOID |
2 |
0.0003 |
| 472 |
LACRIMATION INCREASED |
8 |
0.0003 |
| 473 |
EMOTIONAL DISTRESS |
32 |
0.0003 |
| 474 |
POLLAKIURIA |
11 |
0.0003 |
| 475 |
CONJUNCTIVAL HAEMORRHAGE |
1 |
0.0003 |
| 476 |
CLAVICLE FRACTURE |
1 |
0.0003 |
| 477 |
MADAROSIS |
3 |
0.0003 |
| 478 |
MUSCULOSKELETAL CHEST PAIN |
4 |
0.0003 |
| 479 |
APNOEA |
2 |
0.0003 |
| 480 |
BRAIN FOG |
4 |
0.0003 |
| 481 |
PRODUCT ADMINISTRATION INTERRUPTED |
2 |
0.0003 |
| 482 |
BACTERAEMIA |
3 |
0.0003 |
| 483 |
NASAL DISCOMFORT |
2 |
0.0003 |
| 484 |
RESPIRATORY TRACT CONGESTION |
4 |
0.0003 |
| 485 |
GINGIVAL PAIN |
2 |
0.0003 |
| 486 |
UPPER LIMB FRACTURE |
5 |
0.0003 |
| 487 |
WOUND |
7 |
0.0003 |
| 488 |
AZOTAEMIA |
1 |
0.0003 |
| 489 |
PRODUCT USE ISSUE |
47 |
0.0002 |
| 490 |
CREATININE RENAL CLEARANCE DECREASED |
1 |
0.0002 |
| 491 |
INCORRECT DRUG ADMINISTRATION DURATION |
7 |
0.0002 |
| 492 |
CYSTITIS HAEMORRHAGIC |
1 |
0.0002 |
| 493 |
STOMATITIS |
15 |
0.0002 |
| 494 |
VERTIGO |
15 |
0.0002 |
| 495 |
SWELLING FACE |
16 |
0.0002 |
| 496 |
PYREXIA |
85 |
0.0002 |
| 497 |
DISEASE PROGRESSION |
29 |
0.0002 |
| 498 |
HYPERAESTHESIA |
2 |
0.0002 |
| 499 |
MANIA |
4 |
0.0002 |
| 500 |
TINNITUS |
11 |
0.0002 |
| 501 |
OROPHARYNGEAL PAIN |
22 |
0.0002 |
| 502 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
1 |
0.0002 |
| 503 |
CANDIDA INFECTION |
4 |
0.0002 |
| 504 |
DECREASED APPETITE |
55 |
0.0002 |
| 505 |
COGNITIVE DISORDER |
11 |
0.0002 |
| 506 |
ABSCESS LIMB |
1 |
0.0002 |
| 507 |
RENAL FAILURE |
31 |
0.0002 |
| 508 |
FATIGUE |
181 |
0.0002 |
| 509 |
BLOOD MAGNESIUM DECREASED |
2 |
0.0002 |
| 510 |
SEPTIC SHOCK |
10 |
0.0002 |
| 511 |
LOCAL SWELLING |
4 |
0.0002 |
| 512 |
PRURITUS |
88 |
0.0002 |
| 513 |
RASH MACULAR |
8 |
0.0002 |
| 514 |
INTERVERTEBRAL DISC PROTRUSION |
5 |
0.0002 |
| 515 |
IMMUNE SYSTEM DISORDER |
3 |
0.0002 |
| 516 |
TOOTH INFECTION |
3 |
0.0002 |
| 517 |
IMMUNOSUPPRESSION |
2 |
0.0002 |
| 518 |
PURPURA |
2 |
0.0002 |
| 519 |
LETHARGY |
13 |
0.0002 |
| 520 |
DRUG ERUPTION |
4 |
0.0002 |
| 521 |
EAR INFECTION |
6 |
0.0002 |
| 522 |
DRY SKIN |
30 |
0.0002 |
| 523 |
HEPATOTOXICITY |
5 |
0.0002 |
| 524 |
GLOSSODYNIA |
5 |
0.0002 |
| 525 |
PAIN |
137 |
0.0002 |
| 526 |
THERAPEUTIC RESPONSE UNEXPECTED |
10 |
0.0002 |
| 527 |
ACUTE KIDNEY INJURY |
34 |
0.0002 |
| 528 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
40 |
0.0002 |
| 529 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
1 |
0.0002 |
| 530 |
LEUKOPENIA |
11 |
0.0002 |
| 531 |
ABDOMINAL HERNIA |
1 |
0.0002 |
| 532 |
EXOSTOSIS |
2 |
0.0002 |
| 533 |
PNEUMONIA BACTERIAL |
2 |
0.0002 |
| 534 |
BUNDLE BRANCH BLOCK RIGHT |
1 |
0.0002 |
| 535 |
BACK PAIN |
50 |
0.0002 |
| 536 |
THINKING ABNORMAL |
4 |
0.0002 |
| 537 |
BACTERIAL INFECTION |
4 |
0.0002 |
| 538 |
THERAPY CESSATION |
11 |
0.0002 |
| 539 |
DEFORMITY |
2 |
0.0002 |
| 540 |
SWELLING |
20 |
0.0002 |
| 541 |
DISCOMFORT |
13 |
0.0002 |
| 542 |
BLINDNESS UNILATERAL |
3 |
0.0002 |
| 543 |
ARTERIOSCLEROSIS |
2 |
0.0002 |
| 544 |
FOOT FRACTURE |
4 |
0.0002 |
| 545 |
SPUTUM DISCOLOURED |
2 |
0.0002 |
| 546 |
BLOOD URINE PRESENT |
4 |
0.0002 |
| 547 |
PRODUCT PACKAGING ISSUE |
2 |
0.0002 |
| 548 |
PRODUCT PRESCRIBING ERROR |
5 |
0.0002 |
| 549 |
EYE INFLAMMATION |
2 |
0.0002 |
| 550 |
DRUG PRESCRIBING ERROR |
4 |
0.0002 |
| 551 |
DRUG INTERACTION |
33 |
0.0002 |
| 552 |
APHAGIA |
1 |
0.0002 |
| 553 |
AUTOIMMUNE DISORDER |
2 |
0.0002 |
| 554 |
VITAMIN D DEFICIENCY |
2 |
0.0002 |
| 555 |
CONDITION AGGRAVATED |
62 |
0.0002 |
| 556 |
HOSPICE CARE |
2 |
0.0002 |
| 557 |
DRUG EFFECT LESS THAN EXPECTED |
3 |
0.0002 |
| 558 |
MUSCULAR WEAKNESS |
23 |
0.0002 |
| 559 |
AGEUSIA |
5 |
0.0002 |
| 560 |
DRY EYE |
10 |
0.0002 |
| 561 |
ANXIETY |
57 |
0.0002 |
| 562 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 563 |
APHASIA |
6 |
0.0002 |
| 564 |
VAGINAL DISCHARGE |
2 |
0.0002 |
| 565 |
FEEDING DISORDER |
4 |
0.0002 |
| 566 |
PSORIATIC ARTHROPATHY |
8 |
0.0002 |
| 567 |
CARDIOVASCULAR DISORDER |
5 |
0.0002 |
| 568 |
PANCYTOPENIA |
11 |
0.0002 |
| 569 |
TOOTH ABSCESS |
2 |
0.0002 |
| 570 |
DRUG DISPENSING ERROR |
3 |
0.0002 |
| 571 |
NEUTROPHIL COUNT INCREASED |
2 |
0.0002 |
| 572 |
CACHEXIA |
1 |
0.0002 |
| 573 |
TEMPERATURE INTOLERANCE |
2 |
0.0002 |
| 574 |
BENIGN PROSTATIC HYPERPLASIA |
1 |
0.0002 |
| 575 |
TOOTH LOSS |
4 |
0.0002 |
| 576 |
DRUG EFFECT INCOMPLETE |
7 |
0.0002 |
| 577 |
SWOLLEN TONGUE |
6 |
0.0002 |
| 578 |
RESPIRATORY TRACT INFECTION |
5 |
0.0002 |
| 579 |
TRANSFUSION |
2 |
0.0002 |
| 580 |
POOR QUALITY PRODUCT ADMINISTERED |
2 |
0.0002 |
| 581 |
DERMATITIS ATOPIC |
10 |
0.0002 |
| 582 |
OCULAR HYPERAEMIA |
9 |
0.0002 |
| 583 |
PNEUMOTHORAX |
3 |
0.0002 |
| 584 |
FULL BLOOD COUNT ABNORMAL |
2 |
0.0002 |
| 585 |
ANORECTAL DISCOMFORT |
1 |
0.0002 |
| 586 |
ABSCESS |
3 |
0.0002 |
| 587 |
MOVEMENT DISORDER |
6 |
0.0002 |
| 588 |
RHINORRHOEA |
12 |
0.0002 |
| 589 |
ANAL ABSCESS |
1 |
0.0002 |
| 590 |
PHARYNGITIS STREPTOCOCCAL |
2 |
0.0002 |
| 591 |
ALTERED STATE OF CONSCIOUSNESS |
4 |
0.0002 |
| 592 |
MENSTRUATION DELAYED |
2 |
0.0002 |
| 593 |
PNEUMONITIS |
5 |
0.0002 |
| 594 |
ASTHENIA |
69 |
0.0002 |
| 595 |
IMPAIRED HEALING |
6 |
0.0002 |
| 596 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
13 |
0.0002 |
| 597 |
WOUND INFECTION |
2 |
0.0002 |
| 598 |
GASTROINTESTINAL PAIN |
2 |
0.0002 |
| 599 |
HAEMORRHAGE |
19 |
0.0002 |
| 600 |
SKIN BURNING SENSATION |
13 |
0.0002 |
| 601 |
DRUG LEVEL INCREASED |
3 |
0.0002 |
| 602 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
2 |
0.0002 |
| 603 |
EXPIRED PRODUCT ADMINISTERED |
6 |
0.0002 |
| 604 |
MUSCLE SPASMS |
33 |
0.0002 |
| 605 |
URINARY RETENTION |
6 |
0.0002 |
| 606 |
ADVERSE DRUG REACTION |
16 |
0.0002 |
| 607 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
3 |
0.0002 |
| 608 |
CIRCULATORY COLLAPSE |
3 |
0.0002 |
| 609 |
MYOCARDIAL ISCHAEMIA |
2 |
0.0002 |
| 610 |
MICTURITION URGENCY |
2 |
0.0002 |
| 611 |
INTERNAL HAEMORRHAGE |
2 |
0.0002 |
| 612 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
3 |
0.0002 |
| 613 |
MULTI-ORGAN FAILURE |
3 |
0.0002 |
| 614 |
DELIRIUM |
6 |
0.0002 |
| 615 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
4 |
0.0002 |
| 616 |
MALAISE |
75 |
0.0002 |
| 617 |
SPLENOMEGALY |
2 |
0.0002 |
| 618 |
HYPOXIA |
6 |
0.0002 |
| 619 |
COVID-19 PNEUMONIA |
2 |
0.0002 |
| 620 |
CATARACT OPERATION |
1 |
0.0002 |
| 621 |
ACCIDENT |
2 |
0.0002 |
| 622 |
BURSITIS |
2 |
0.0002 |
| 623 |
DERMATITIS ACNEIFORM |
1 |
0.0002 |
| 624 |
NO THERAPEUTIC RESPONSE |
2 |
0.0002 |
| 625 |
DYSURIA |
6 |
0.0002 |
| 626 |
GAIT DISTURBANCE |
31 |
0.0002 |
| 627 |
CONJUNCTIVITIS |
3 |
0.0002 |
| 628 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
4 |
0.0002 |
| 629 |
HAIR COLOUR CHANGES |
2 |
0.0002 |
| 630 |
MIDDLE INSOMNIA |
3 |
0.0002 |
| 631 |
EYE PAIN |
9 |
0.0002 |
| 632 |
BLEPHAROSPASM |
1 |
0.0002 |
| 633 |
HEPATIC CYTOLYSIS |
2 |
0.0002 |
| 634 |
HYPOPHAGIA |
4 |
0.0002 |
| 635 |
CHOLESTASIS |
3 |
0.0002 |
| 636 |
MYDRIASIS |
2 |
0.0002 |
| 637 |
GENITAL HAEMORRHAGE |
2 |
0.0002 |
| 638 |
CARDIAC FLUTTER |
1 |
0.0002 |
| 639 |
RASH GENERALISED |
4 |
0.0002 |
| 640 |
DIPLOPIA |
4 |
0.0002 |
| 641 |
NODULE |
2 |
0.0002 |
| 642 |
DEAFNESS |
4 |
0.0002 |
| 643 |
NEPHROLITHIASIS |
7 |
0.0002 |
| 644 |
INFLUENZA |
17 |
0.0002 |
| 645 |
ORAL CANDIDIASIS |
2 |
0.0002 |
| 646 |
HEADACHE |
95 |
0.0002 |
| 647 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
3 |
0.0002 |
| 648 |
THERAPEUTIC RESPONSE SHORTENED |
5 |
0.0002 |
| 649 |
QUALITY OF LIFE DECREASED |
2 |
0.0001 |
| 650 |
FEAR |
4 |
0.0001 |
| 651 |
SINUS CONGESTION |
2 |
0.0001 |
| 652 |
THROAT TIGHTNESS |
4 |
0.0001 |
| 653 |
RASH PRURITIC |
8 |
0.0001 |
| 654 |
BODY TEMPERATURE INCREASED |
3 |
0.0001 |
| 655 |
RASH |
64 |
0.0001 |
| 656 |
GINGIVAL BLEEDING |
2 |
0.0001 |
| 657 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
7 |
0.0001 |
| 658 |
NAUSEA |
114 |
0.0001 |
| 659 |
MEDICATION ERROR |
8 |
0.0001 |
| 660 |
APHONIA |
2 |
0.0001 |
| 661 |
URTICARIA |
24 |
0.0001 |
| 662 |
NECK PAIN |
8 |
0.0001 |
| 663 |
MASS |
2 |
0.0001 |
| 664 |
RENAL IMPAIRMENT |
12 |
0.0001 |
| 665 |
BLOOD TEST ABNORMAL |
2 |
0.0001 |
| 666 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 667 |
PRODUCT DOSE OMISSION IN ERROR |
4 |
0.0001 |
| 668 |
PAIN IN JAW |
4 |
0.0001 |
| 669 |
RED BLOOD CELL COUNT DECREASED |
4 |
0.0001 |
| 670 |
POOR QUALITY SLEEP |
3 |
0.0001 |
| 671 |
CELLULITIS |
7 |
0.0001 |
| 672 |
PRURITUS GENERALISED |
3 |
0.0001 |
| 673 |
FAECES DISCOLOURED |
3 |
0.0001 |
| 674 |
MYELODYSPLASTIC SYNDROME |
2 |
0.0001 |
| 675 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
28 |
0.0001 |
| 676 |
ANOSMIA |
2 |
0.0001 |
| 677 |
PSORIASIS |
18 |
0.0001 |
| 678 |
PRODUCT DISPENSING ERROR |
3 |
0.0001 |
| 679 |
ALOPECIA |
27 |
0.0001 |
| 680 |
MUSCULOSKELETAL STIFFNESS |
12 |
0.0001 |
| 681 |
DIZZINESS |
68 |
0.0001 |
| 682 |
NASAL CONGESTION |
8 |
0.0001 |
| 683 |
ILLNESS |
14 |
0.0001 |
| 684 |
ACCIDENTAL EXPOSURE TO PRODUCT |
14 |
0.0001 |
| 685 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 686 |
LABORATORY TEST ABNORMAL |
4 |
0.0001 |
| 687 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 688 |
PULMONARY MASS |
2 |
0.0001 |
| 689 |
THROAT IRRITATION |
6 |
0.0001 |
| 690 |
MUSCULOSKELETAL PAIN |
7 |
0.0001 |
| 691 |
ATRIAL FIBRILLATION |
13 |
0.0001 |
| 692 |
CORONARY ARTERY DISEASE |
4 |
0.0001 |
| 693 |
ACNE |
10 |
0.0001 |
| 694 |
AORTIC ANEURYSM |
1 |
0.0001 |
| 695 |
INSOMNIA |
35 |
0.0001 |
| 696 |
VISION BLURRED |
18 |
0.0001 |
| 697 |
INSURANCE ISSUE |
2 |
0.0001 |
| 698 |
HIP ARTHROPLASTY |
2 |
0.0001 |
| 699 |
DRUG ADMINISTRATION ERROR |
4 |
0.0001 |
| 700 |
WHITE BLOOD CELL COUNT INCREASED |
5 |
0.0001 |
| 701 |
UPPER RESPIRATORY TRACT INFECTION |
6 |
0.0001 |
| 702 |
DISTURBANCE IN ATTENTION |
7 |
0.0001 |
| 703 |
THYROID DISORDER |
2 |
0.0001 |
| 704 |
DRUG INEFFECTIVE |
171 |
0.0001 |
| 705 |
ANKLE FRACTURE |
2 |
0.0001 |
| 706 |
BRONCHOPULMONARY ASPERGILLOSIS |
1 |
0.0001 |
| 707 |
SLEEP DISORDER |
9 |
0.0001 |
| 708 |
AFFECTIVE DISORDER |
1 |
0.0001 |
| 709 |
SINUSITIS |
13 |
0.0001 |
| 710 |
PRODUCTIVE COUGH |
6 |
0.0001 |
| 711 |
INTENTIONAL PRODUCT MISUSE |
11 |
0.0001 |
| 712 |
PAIN IN EXTREMITY |
37 |
0.0001 |
| 713 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 714 |
ARTHRALGIA |
52 |
0.0001 |
| 715 |
LOSS OF CONSCIOUSNESS |
16 |
0.0001 |
| 716 |
HIP FRACTURE |
4 |
0.0001 |
| 717 |
INFECTION |
18 |
0.0001 |
| 718 |
DRUG INTOLERANCE |
12 |
0.0001 |
| 719 |
FLATULENCE |
7 |
0.0001 |
| 720 |
PERIPHERAL SWELLING |
19 |
0.0001 |
| 721 |
DECUBITUS ULCER |
1 |
0.0001 |
| 722 |
AGITATION |
9 |
0.0001 |
| 723 |
ABNORMAL FAECES |
1 |
0.0001 |
| 724 |
BRONCHITIS |
9 |
0.0001 |
| 725 |
PRODUCT SUBSTITUTION ISSUE |
7 |
0.0001 |
| 726 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 727 |
FUNGAL INFECTION |
4 |
0.0001 |
| 728 |
SYNCOPE |
12 |
0.0001 |
| 729 |
DYSPHONIA |
7 |
0.0001 |
| 730 |
HYPOTENSION |
24 |
0.0001 |
| 731 |
ROAD TRAFFIC ACCIDENT |
5 |
0.0001 |
| 732 |
HALLUCINATION |
9 |
0.0001 |
| 733 |
SURGERY |
7 |
0.0001 |
| 734 |
FACE OEDEMA |
2 |
0.0001 |
| 735 |
HYPERSENSITIVITY |
22 |
0.0001 |
| 736 |
RENAL FAILURE ACUTE |
5 |
0.0001 |
| 737 |
CATARACT |
7 |
0.0001 |
| 738 |
NEUROPATHY PERIPHERAL |
11 |
0.0001 |
| 739 |
ORTHOSTATIC HYPOTENSION |
2 |
0.0001 |
| 740 |
DIARRHOEA |
74 |
0.0001 |
| 741 |
METASTASES TO LIVER |
2 |
0.0001 |
| 742 |
CHEST PAIN |
21 |
0.0001 |
| 743 |
BLOOD TRIGLYCERIDES INCREASED |
2 |
0.0001 |
| 744 |
LYMPHOCYTE COUNT DECREASED |
2 |
0.0001 |
| 745 |
HEAD DISCOMFORT |
2 |
0.0001 |
| 746 |
THIRST |
2 |
0.0001 |
| 747 |
GOUT |
2 |
0.0001 |
| 748 |
PNEUMONIA |
36 |
0.0001 |
| 749 |
GASTROENTERITIS VIRAL |
2 |
0.0001 |
| 750 |
BONE DISORDER |
2 |
0.0001 |
| 751 |
RESPIRATORY DISTRESS |
3 |
0.0001 |
| 752 |
ABNORMAL DREAMS |
3 |
0.0001 |
| 753 |
WEIGHT DECREASED |
30 |
0.0001 |
| 754 |
PRODUCT DOSE OMISSION |
7 |
0.0001 |
| 755 |
BLOOD CREATININE INCREASED |
7 |
0.0001 |
| 756 |
APPENDICITIS |
1 |
0.0001 |
| 757 |
PHOTOPHOBIA |
2 |
0.0001 |
| 758 |
DYSPNOEA EXERTIONAL |
4 |
0.0001 |
| 759 |
BLOOD SODIUM DECREASED |
2 |
0.0001 |
| 760 |
DEPRESSION |
24 |
0.0001 |
| 761 |
PULMONARY EMBOLISM |
10 |
0.0001 |
| 762 |
INTENTIONAL DOSE OMISSION |
3 |
0.0001 |
| 763 |
FEELING JITTERY |
2 |
0.0001 |
| 764 |
INCREASED APPETITE |
2 |
0.0001 |
| 765 |
HYPERSOMNIA |
3 |
0.0001 |
| 766 |
PULMONARY FIBROSIS |
2 |
0.0001 |
| 767 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
3 |
0.0001 |
| 768 |
BALANCE DISORDER |
9 |
0.0001 |
| 769 |
HEPATIC ENZYME INCREASED |
7 |
0.0001 |
| 770 |
BLOOD PRESSURE SYSTOLIC INCREASED |
2 |
0.0001 |
| 771 |
DECREASED IMMUNE RESPONSIVENESS |
1 |
0.0001 |
| 772 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 773 |
ABDOMINAL DISCOMFORT |
17 |
0.0001 |
| 774 |
URINARY INCONTINENCE |
3 |
0.0001 |
| 775 |
WHEEZING |
6 |
0.0001 |
| 776 |
RENAL INJURY |
3 |
0.0001 |
| 777 |
HYPERHIDROSIS |
13 |
0.0001 |
| 778 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 779 |
RESPIRATORY DISORDER |
3 |
0.0001 |
| 780 |
SPINAL FRACTURE |
2 |
0.0001 |
| 781 |
GASTROOESOPHAGEAL REFLUX DISEASE |
8 |
0.0001 |
| 782 |
PRODUCT PHYSICAL ISSUE |
2 |
0.0001 |
| 783 |
PLEURAL EFFUSION |
6 |
0.0001 |
| 784 |
BLINDNESS |
4 |
0.0001 |
| 785 |
NEUTROPHIL COUNT DECREASED |
4 |
0.0001 |
| 786 |
EPILEPSY |
3 |
0.0001 |
| 787 |
FEELING HOT |
6 |
0.0001 |
| 788 |
DEHYDRATION |
13 |
0.0001 |
| 789 |
LIMB DISCOMFORT |
3 |
0.0001 |
| 790 |
VISUAL IMPAIRMENT |
12 |
0.0001 |
| 791 |
PERITONITIS |
2 |
0.0001 |
| 792 |
NEUTROPENIA |
13 |
0.0001 |
| 793 |
DYSPHAGIA |
9 |
0.0001 |
| 794 |
HALLUCINATION, VISUAL |
2 |
0.0001 |
| 795 |
DEPRESSED MOOD |
5 |
0.0001 |
| 796 |
ANAEMIA |
18 |
0.0001 |
| 797 |
MIGRAINE |
9 |
0.0001 |
| 798 |
PLATELET COUNT DECREASED |
10 |
0.0001 |
| 799 |
BREAST PAIN |
1 |
0.0001 |
| 800 |
IMPAIRED WORK ABILITY |
2 |
0.0001 |
| 801 |
IRRITABLE BOWEL SYNDROME |
2 |
0.0001 |
| 802 |
COUGH |
26 |
0.0001 |
| 803 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
2 |
0.0001 |
| 804 |
ABDOMINAL PAIN UPPER |
19 |
0.0001 |
| 805 |
WHITE BLOOD CELL COUNT DECREASED |
10 |
0.0001 |
| 806 |
BIPOLAR DISORDER |
1 |
0.0001 |
| 807 |
DIABETES MELLITUS |
7 |
0.0001 |
| 808 |
INTENTIONAL PRODUCT USE ISSUE |
8 |
0.0001 |
| 809 |
ASPIRATION |
1 |
0.0001 |
| 810 |
EYE DISORDER |
3 |
0.0001 |
| 811 |
TOOTH DISORDER |
2 |
0.0001 |
| 812 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
4 |
0.0001 |
| 813 |
SNEEZING |
2 |
0.0001 |
| 814 |
TRANSIENT ISCHAEMIC ATTACK |
3 |
0.0001 |
| 815 |
ASTHMA |
10 |
0.0001 |
| 816 |
HAEMOGLOBIN DECREASED |
9 |
0.0001 |
| 817 |
FALL |
29 |
0.0001 |
| 818 |
GENERAL PHYSICAL HEALTH DETERIORATION |
10 |
0.0001 |
| 819 |
DRY MOUTH |
7 |
0.0001 |
| 820 |
ABDOMINAL PAIN |
20 |
0.0001 |
| 821 |
COVID-19 |
15 |
0.0001 |
| 822 |
HYPERTENSION |
18 |
0.0001 |
| 823 |
DYSPNOEA |
48 |
0.0001 |
| 824 |
ARRHYTHMIA |
4 |
0.0001 |
| 825 |
ATAXIA |
1 |
0.0001 |
| 826 |
MULTIPLE SCLEROSIS |
4 |
0.0001 |
| 827 |
IRRITABILITY |
5 |
0.0001 |
| 828 |
PARAESTHESIA |
13 |
0.0001 |
| 829 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
3 |
0.0001 |
| 830 |
CRYING |
3 |
0.0001 |
| 831 |
CONSTIPATION |
18 |
0.0001 |
| 832 |
MENTAL IMPAIRMENT |
2 |
0.0001 |
| 833 |
THERAPEUTIC RESPONSE DECREASED |
5 |
0.0001 |
| 834 |
NEURALGIA |
2 |
0.0001 |
| 835 |
CYTOPENIA |
1 |
0.0001 |
| 836 |
LUNG DISORDER |
4 |
0.0001 |
| 837 |
PRODUCT DOSE OMISSION ISSUE |
24 |
0.0001 |
| 838 |
ABASIA |
2 |
0.0001 |
| 839 |
SEPSIS |
9 |
0.0001 |
| 840 |
HYPOAESTHESIA |
12 |
0.0001 |
| 841 |
PRODUCT STORAGE ERROR |
7 |
0.0001 |
| 842 |
INTESTINAL OBSTRUCTION |
3 |
0.0001 |
| 843 |
UNEVALUABLE EVENT |
6 |
0.0001 |
| 844 |
FEELING ABNORMAL |
19 |
0.0001 |
| 845 |
BRAIN OEDEMA |
1 |
0.0001 |
| 846 |
FLUSHING |
8 |
0.0001 |
| 847 |
FLUID RETENTION |
4 |
0.0001 |
| 848 |
MALIGNANT NEOPLASM PROGRESSION |
8 |
0.0001 |
| 849 |
HAEMATOMA |
2 |
0.0001 |
| 850 |
VOMITING |
36 |
0.0001 |
| 851 |
JOINT STIFFNESS |
2 |
0.0001 |
| 852 |
URINARY TRACT INFECTION |
13 |
0.0001 |
| 853 |
NASOPHARYNGITIS |
14 |
0.0001 |
| 854 |
BRADYCARDIA |
4 |
0.0001 |
| 855 |
NEOPLASM MALIGNANT |
5 |
0.0001 |
| 856 |
LIMB INJURY |
2 |
0.0001 |
| 857 |
PRODUCT QUALITY ISSUE |
10 |
0.0001 |
| 858 |
MOOD ALTERED |
2 |
0.0001 |
| 859 |
DIVERTICULITIS |
2 |
0.0001 |
| 860 |
ARTHROPATHY |
4 |
0.0001 |
| 861 |
RHABDOMYOLYSIS |
3 |
0.0001 |
| 862 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 863 |
DYSPEPSIA |
7 |
0.0001 |
| 864 |
OSTEOARTHRITIS |
3 |
0.0001 |
| 865 |
THERAPY INTERRUPTED |
5 |
0.0001 |
| 866 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 867 |
MOBILITY DECREASED |
5 |
0.0001 |
| 868 |
VAGINAL HAEMORRHAGE |
3 |
0.0001 |
| 869 |
NEEDLE ISSUE |
2 |
0.0001 |
| 870 |
DYSSTASIA |
2 |
0.0001 |
| 871 |
BONE PAIN |
4 |
0.0001 |
| 872 |
ASCITES |
2 |
0.0001 |
| 873 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 874 |
PULMONARY OEDEMA |
3 |
0.0001 |
| 875 |
GASTROINTESTINAL DISORDER |
6 |
0.0001 |
| 876 |
BLOOD POTASSIUM DECREASED |
2 |
0.0001 |
| 877 |
JOINT SWELLING |
8 |
0.0001 |
| 878 |
NO ADVERSE EVENT |
12 |
0.0001 |
| 879 |
LOWER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 880 |
ALANINE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 881 |
ADVERSE EVENT |
6 |
0.0001 |
| 882 |
HYPOKALAEMIA |
3 |
0.0001 |
| 883 |
SOMNOLENCE |
13 |
0.0001 |
| 884 |
RENAL DISORDER |
3 |
0.0001 |
| 885 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 886 |
HEAD INJURY |
2 |
0.0001 |
| 887 |
CARDIAC FAILURE CONGESTIVE |
5 |
0.0001 |
| 888 |
BACK DISORDER |
1 |
0.0001 |
| 889 |
AMNESIA |
4 |
0.0001 |
| 890 |
CHOLELITHIASIS |
2 |
0.0001 |
| 891 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 892 |
CYTOMEGALOVIRUS INFECTION |
1 |
0.0001 |
| 893 |
VIRAL INFECTION |
2 |
0.0001 |
| 894 |
PALPITATIONS |
7 |
0.0001 |
| 895 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 896 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
2 |
0.0001 |
| 897 |
CHEST DISCOMFORT |
6 |
0.0001 |
| 898 |
HAEMATURIA |
2 |
0.0001 |
| 899 |
INJECTION SITE REACTION |
4 |
0.0001 |
| 900 |
NIGHTMARE |
2 |
0.0001 |
| 901 |
NEOPLASM PROGRESSION |
2 |
0.0001 |
| 902 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
3 |
0.0001 |
| 903 |
OEDEMA PERIPHERAL |
7 |
0.0001 |
| 904 |
NERVOUSNESS |
3 |
0.0001 |
| 905 |
ECZEMA |
3 |
0.0001 |
| 906 |
HEART RATE DECREASED |
2 |
0.0001 |
| 907 |
DEVICE MALFUNCTION |
4 |
0.0001 |
| 908 |
PANCREATITIS |
3 |
0.0001 |
| 909 |
COLD SWEAT |
1 |
0.0001 |
| 910 |
ASPARTATE AMINOTRANSFERASE INCREASED |
3 |
0.0001 |
| 911 |
INJECTION SITE ERYTHEMA |
7 |
0.0001 |
| 912 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
2 |
0.0001 |
| 913 |
CEREBRAL HAEMORRHAGE |
2 |
0.0001 |
| 914 |
CONFUSIONAL STATE |
9 |
0.0001 |
| 915 |
RESPIRATORY FAILURE |
4 |
0.0001 |
| 916 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 917 |
DRUG DOSE OMISSION |
9 |
0.0001 |
| 918 |
TREMOR |
9 |
0.0001 |
| 919 |
OXYGEN SATURATION DECREASED |
3 |
0.0001 |
| 920 |
INCORRECT DOSE ADMINISTERED |
12 |
0.0001 |
| 921 |
CONTUSION |
5 |
0.0001 |
| 922 |
ARTHRITIS |
4 |
0.0001 |
| 923 |
ABNORMAL BEHAVIOUR |
2 |
0.0001 |
| 924 |
HEART RATE INCREASED |
5 |
0.0001 |
| 925 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 926 |
THROMBOSIS |
4 |
0.0000 |
| 927 |
EXTRA DOSE ADMINISTERED |
2 |
0.0000 |
| 928 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 929 |
CARDIAC ARREST |
4 |
0.0000 |
| 930 |
ABDOMINAL DISTENSION |
5 |
0.0000 |
| 931 |
HYPOACUSIS |
2 |
0.0000 |
| 932 |
DEVICE DISLOCATION |
2 |
0.0000 |
| 933 |
MENTAL DISORDER |
2 |
0.0000 |
| 934 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 935 |
FEBRILE NEUTROPENIA |
3 |
0.0000 |
| 936 |
ANGIOEDEMA |
2 |
0.0000 |
| 937 |
LIVER DISORDER |
2 |
0.0000 |
| 938 |
TACHYCARDIA |
4 |
0.0000 |
| 939 |
THROMBOCYTOPENIA |
5 |
0.0000 |
| 940 |
CHROMATURIA |
1 |
0.0000 |
| 941 |
SUICIDAL IDEATION |
4 |
0.0000 |
| 942 |
COMA |
2 |
0.0000 |
| 943 |
OVERDOSE |
9 |
0.0000 |
| 944 |
BLOOD GLUCOSE DECREASED |
2 |
0.0000 |
| 945 |
INTERSTITIAL LUNG DISEASE |
2 |
0.0000 |
| 946 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 947 |
EPISTAXIS |
3 |
0.0000 |
| 948 |
AGGRESSION |
2 |
0.0000 |
| 949 |
BLOOD PRESSURE INCREASED |
6 |
0.0000 |
| 950 |
SPEECH DISORDER |
2 |
0.0000 |
| 951 |
BREAST CANCER FEMALE |
1 |
0.0000 |
| 952 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 953 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 954 |
GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0000 |
| 955 |
INJECTION SITE PAIN |
11 |
0.0000 |
| 956 |
WEIGHT INCREASED |
8 |
0.0000 |
| 957 |
DEATH |
30 |
0.0000 |
| 958 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 959 |
MATERNAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 960 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 961 |
ILL-DEFINED DISORDER |
2 |
0.0000 |
| 962 |
BREAST CANCER |
3 |
0.0000 |
| 963 |
CYSTITIS |
1 |
0.0000 |
| 964 |
INTENTIONAL OVERDOSE |
2 |
0.0000 |
| 965 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 966 |
INJECTION SITE PRURITUS |
2 |
0.0000 |
| 967 |
TOXICITY TO VARIOUS AGENTS |
5 |
0.0000 |
| 968 |
ANGER |
1 |
0.0000 |
| 969 |
INJURY |
2 |
0.0000 |
| 970 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 971 |
HOT FLUSH |
2 |
0.0000 |
| 972 |
RHEUMATOID ARTHRITIS |
3 |
0.0000 |
| 973 |
COLITIS |
1 |
0.0000 |
| 974 |
HOSPITALISATION |
4 |
0.0000 |
| 975 |
SEIZURE |
3 |
0.0000 |
| 976 |
INJECTION SITE HAEMORRHAGE |
2 |
0.0000 |
| 977 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 978 |
CEREBROVASCULAR ACCIDENT |
4 |
0.0000 |
| 979 |
MYOCARDIAL INFARCTION |
4 |
0.0000 |
| 980 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 981 |
CARDIAC DISORDER |
2 |
0.0000 |
| 982 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 983 |
BLOOD GLUCOSE INCREASED |
3 |
0.0000 |
| 984 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 985 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 986 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 987 |
DRUG DEPENDENCE |
2 |
0.0000 |